Bhowmik, Srijita http://orcid.org/0000-0001-5951-4557
Galeta, Juraj http://orcid.org/0000-0002-7729-1825
Havel, Václav http://orcid.org/0000-0002-6911-4669
Nelson, Melissa http://orcid.org/0000-0001-8007-2001
Faouzi, Abdelfattah http://orcid.org/0000-0002-9059-4791
Bechand, Benjamin
Ansonoff, Mike http://orcid.org/0000-0001-8607-2897
Fiala, Tomas http://orcid.org/0000-0001-6949-4561
Hunkele, Amanda
Kruegel, Andrew C.
Pintar, John. E. http://orcid.org/0000-0001-5945-569X
Majumdar, Susruta http://orcid.org/0000-0002-2931-3823
Javitch, Jonathan A. http://orcid.org/0000-0001-7395-2967
Sames, Dalibor http://orcid.org/0000-0001-6911-2260
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (R01DA046487, R21DA045884, R21MH1164620)
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse
U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism (AA026949)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30 CA008748)
Article History
Received: 2 August 2020
Accepted: 13 May 2021
First Online: 22 June 2021
Competing interests
: S.B., J.G., V.H., A.C.K., J.A.J., S.M., and D.S., are named as inventors on patent applications related to mitragynine analogs. A.C.K., J.A.J., and D.S. are co-founders of Kures, Inc. S.M. is a co-founder of Sparian biosciences. The authors M.N., A.F., B.B., M.A., T.F., A.H., and J.E.P. declare no competing interests.